Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Financial Results:
Gufic BioSciences Ltd reported Revenues for Q1FY25 of ₹203.00 Crores up from ₹195.00 Crore year on year, a rise of 4.1%.
Total Expenses for Q1FY25 of ₹176.00 Crores up from ₹168.00 Crores year on year, a rise of 4.76%.
Consolidated Net Profit of ₹21.00 Crores from ₹21.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.08, down 2.35% from ₹2.13 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.